Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers (Q38190856)

30 August 2017

1 reference

title

Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers (English)

1 reference

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566712%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Y-J Chang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566712%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

24 February 2014

1 reference

Bone Marrow Transplantation

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566712%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566712%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566712%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

873-879

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566712%20AND%20SRC:MED&resulttype=core&format=json

Haploidentical hematopoietic stem cell transplantation with unmanipulated granulocyte colony stimulating factor mobilized marrow and blood grafts.

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Haploidentical bone marrow transplantation without T-cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Haploidentical hematopoietic transplantation: current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Haploidentical related-donor hematopoietic cell transplantation in children using megadoses of CliniMACs-selected CD34(+) cells and a fixed CD3(+) dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Interaction of antithymocyte globulins with dendritic cell antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

T cell depletion in paediatric stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Human regulatory T cells of G-CSF mobilized allogeneic stem cell donors qualify for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Antigen presentation in the thymus for positive selection and central tolerance induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Anergic T cells are metabolically anergic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Regulatory T cell induction, migration, and function in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Natural killer cell education and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Mechanisms maintaining peripheral tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Low-dose, but not high-dose, cyclosporin A promotes regulatory T-cell induction, expansion, or both.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Low-dose of tacrolimus favors the induction of functional CD4(+)CD25(+)FoxP3(+) regulatory T cells in solid-organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Immune tolerance and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Promoting transplantation tolerance; adoptive regulatory T cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Innate or adaptive immunity? The example of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Significant mobilization of both conventional and regulatory T cells with AMD3100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Plerixafor-moblized stem cells alone are capable of inducing early engraftment across the MHC-haploidentical canine barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Ex vivo expansion of human Tregs by rabbit ATG is dependent on intact STAT3-signaling in CD4⁺ T cells and requires the presence of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4+ CD25+ T-cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Murine neonates develop vigorous in vivo cytotoxic and Th1/Th2 responses upon exposure to low doses of NIMA-like alloantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Innovative platforms for haploidentical stem cell transplantation: the role of unmanipulated donor graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Haploidentical transplantation in patients with acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.19

Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation

21 January 2018

1 reference

12 December 2020

Regulatory T cells in maintenance and reversal of peripheral tolerance in vivo

1 reference

12 December 2020

Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-

1 reference

12 December 2020

Impact of mycophenolic acid and tacrolimus on Th17-related immune response

1 reference

12 December 2020

T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantati

1 reference

12 December 2020

Haploidentical hematopoietic stem cell transplantation in hematologic malignancies with G-CSF mobilized bone marrow plus peripheral blood stem cells grafts without T cell depletion: a single center report of 29 cases

1 reference

12 December 2020

An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it

1 reference

12 December 2020

Haplo-BMT: which approach?

1 reference

12 December 2020

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

12 December 2020

Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model

1 reference

12 December 2020

G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells

1 reference

12 December 2020

A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing

1 reference

12 December 2020

Levees of immunological tolerance

1 reference

12 December 2020

Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells

1 reference

12 December 2020

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

12 December 2020

Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation.

1 reference

12 December 2020

Immune reconstitution following unmanipulated HLA-mismatched/haploidentical transplantation compared with HLA-identical sibling transplantation

1 reference

12 December 2020

Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies

1 reference

12 December 2020

Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center

1 reference

12 December 2020

The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission

1 reference

12 December 2020

Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free sur

1 reference

12 December 2020

Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo

1 reference

12 December 2020

Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells

1 reference

12 December 2020

Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells

1 reference

12 December 2020

In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.

1 reference

12 December 2020

A role for mammalian target of rapamycin in regulating T cell activation versus anergy

1 reference

12 December 2020